TY - JOUR
T1 - IFN-α2b reduces IL-2 production and IL-2 receptor function in primary CD4+ T cells
AU - Zella, Davide
AU - Romerio, Fabio
AU - Curreli, Sabrina
AU - Secchiero, Paola
AU - Cicala, Claudia
AU - Zagury, Daniel
AU - Gallo, Robert C.
PY - 2000/3/1
Y1 - 2000/3/1
N2 - Initially described as an antiviral cytokine, IFN-α has been subsequently shown to affect several cellular functions, including cellular differentiation and proliferation. For these reasons, IFN-α is currently used in clinical practice for the treatment of viral infections and malignancies. In this manuscript, we show two novel mechanisms concomitantly responsible for the antiproliferative effect of IFN-α. First, long-term treatment with IFN-α of primary CD4+ T cells reduced surface expression of CD3 and CD28. These events resulted in decreased phosphorylation of the mitogen-activated extracellular signal-regulated activating kinase arid its substrate extracellular signal-regulated kinase, leading to diminished production of IL-2. Second, IFN-α treatment of primary CD4+ T cells reduced proliferative response to stimulation in the presence of exogenous IL-2 by markedly decreasing mRNA synthesis and surface expression of CD25 (α-chain), a critical component of the IL-2R complex. These results may be relevant for the antitumor effects of IFN-α and may help us to better understand its detrimental role in the inhibition of proliferation of the bulk of CD4+ T cells (uninfected cells) in HIV-infected persons, who are known to overproduce IFN-α.
AB - Initially described as an antiviral cytokine, IFN-α has been subsequently shown to affect several cellular functions, including cellular differentiation and proliferation. For these reasons, IFN-α is currently used in clinical practice for the treatment of viral infections and malignancies. In this manuscript, we show two novel mechanisms concomitantly responsible for the antiproliferative effect of IFN-α. First, long-term treatment with IFN-α of primary CD4+ T cells reduced surface expression of CD3 and CD28. These events resulted in decreased phosphorylation of the mitogen-activated extracellular signal-regulated activating kinase arid its substrate extracellular signal-regulated kinase, leading to diminished production of IL-2. Second, IFN-α treatment of primary CD4+ T cells reduced proliferative response to stimulation in the presence of exogenous IL-2 by markedly decreasing mRNA synthesis and surface expression of CD25 (α-chain), a critical component of the IL-2R complex. These results may be relevant for the antitumor effects of IFN-α and may help us to better understand its detrimental role in the inhibition of proliferation of the bulk of CD4+ T cells (uninfected cells) in HIV-infected persons, who are known to overproduce IFN-α.
UR - http://www.scopus.com/inward/record.url?scp=0034163310&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034163310&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.164.5.2296
DO - 10.4049/jimmunol.164.5.2296
M3 - Article
C2 - 10679063
AN - SCOPUS:0034163310
SN - 0022-1767
VL - 164
SP - 2296
EP - 2302
JO - Journal of Immunology
JF - Journal of Immunology
IS - 5
ER -